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Viral inhibitionMurine norovirus-1 (MNV-1) shares many features with human norovirus (HuNoV) and both are classiﬁed
within the norovirus genus of Caliciviridae family. MNV-1 is used as the surrogate for HuNoV research
since it is the only form that can be grown in cell culture. HuNoV and MNV-1 RNA dependent RNA polymer-
ase (RdRp) proteins with the sequence identity of 59% show essentially identical conformations. Here we re-
port the ﬁrst structural evidence of 2-thiouridine (2TU) or ribavirin binding to MNV-1 RdRp, based on the
crystal structures determined at 2.2 Å and 2.5 Å resolutions, respectively. Cellular and biochemical studies
revealed stronger inhibitory effect of 2TU on the replication of MNV-1 in RAW 264.7 cells, compared to
that of ribavirin. Our complex structures highlight the key interactions involved in recognition of the nucle-
oside analogs which block the active site of the viral RNA polymerase.
© 2012 Elsevier Inc. All rights reserved.Introduction
The genus norovirus (NV) in the Caliciviridae family causes approx-
imately 90% of epidemic non-bacterial outbreaks of gastroenteritis
around the world (Green, 2007; Lindesmith et al., 2003), commonly re-
ferred to as the gastric ﬂu. Due to the lack of an efﬁcient cell-culture sys-
tem and an animal model to study virus propagation, human NV
(HuNoV) has been relatively understudied. Murine norovirus-1
(MNV-1) from STAT1-deﬁcient (STAT1−/−) mice was successfully
grown in the macrophage cell line RAW 264.7 (Wobus et al., 2004,
2006) and has served as a surrogate model system for studying noro-
virus biology and pathogenesis. However, the molecular mechanisms
of NV replication and pathogenesis remain poorly understood.
The NV genome of a positive-sense single-stranded RNA encodes
three open reading frames: ORF-2 encodes the capsid protein (VP1),
ORF-3 encodes the virion protein 2 (VP2), and ORF-1 encodes non-
structural proteins (Green, 2007; Karst et al., 2003). Studies on NV
RNA replication has focused on the in vitro functions ofFood and Nutrition, Duksung
Fax: +82 2 901 8372.
technology & Bioinformatics,
a. Fax: +82 2 3290 3945.
ng), khkim@korea.ac.kr
rights reserved.non-structural proteins. RNA-dependent RNA polymerase (RdRp)
which is involved in synthesis and ampliﬁcation of viral genome
uses ribonucleotide triphosphate (rNTPs) as substrate with low ﬁdel-
ity and lacks an error-prone repair mechanism. This virally encoded
RdRp is one of the key targets for the development of novel antiviral
agents (Zamyatkin et al., 2008). Nucleoside analogs such as ribavirin
and 5-ﬂuorouracil were shown to induce error in the viral replication
(Ferrer-Orta et al., 2007). The biochemical evidence for the inhibition
of NV replication by ribavirin and IFN-γ in replicon-bearing cells was
previously reported (Chang and George, 2007). Detailed studies on
themechanism of inhibition have shown that ribavirin is incorporated
into viral RNA where it base pairs with UMP or CMP and drives differ-
ent RNA viruses towards extinction through enhanced mutagenesis
(Crotty et al., 2000; Lau et al., 2002). Ribavirin is used as an antiviral
prodrug which is metabolized to active 5′-monophosphate, diphos-
phate and triphosphate in vivo (Wu et al., 2003). Biochemical studies
with 2-thiouridine (2TU) revealed that it not only inhibits the noro-
virus polymerase but also has inhibitory effect on viral growth of
CRFK cells in feline calicivirus (FCV) (Belliot et al., 2005).
A high resolution crystal structure is required to rationalize the in-
hibitory activity of these compounds on viral RdRp. The only structure
available for the viral polymerase in complex with ribavirin is that of
foot and mouth disease virus (FMDV) which showed the binding of
ribavirin at the active site (Ferrer-Orta et al., 2007), while structural
evidence for binding of 2TU with viral RdRp is lacking. The structures
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144 I. Alam et al. / Virology 426 (2012) 143–151of NV RdRp in complex with template RNA duplex and nucleotides
were reported (Zamyatkin et al., 2008, 2009). These structures pro-
vide valuable insight about the mechanism involved in recognition
and positioning of nucleotides at the active site of RdRp.
In the present study we have solved the structures of MNV-1 RdRp
in complex with 2TU or ribavirin and have studied their inhibitory ef-
fects on MNV-1 replication in RAW 264.7 cells. To our knowledge this
is the ﬁrst structural report describing the binding modes of 2TU and
ribavirin in calicivirus RdRp and the ﬁrst inhibitory report of 2TU on
MNV-1 in RAW 264.7 cells. In the light of novel therapeutic strategies
aiming at blocking the replication complex of NV through inhibition
of viral enzyme interaction, our results can be used to design some
rational antiviral compounds for noroviral RNA polymerases.Concentration (µM)
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Effect of 2TU or ribavirin on MNV-1 in infected cells and RdRp enzyme
Two commercially available viral nucleoside analogs (2TU and
ribavirin) were tested for their inhibitory effect on the growth of
MNV-1 in RAW 264.7 cells. Although the inhibitory activity of
ribavirin has been studied previously (Chang and George, 2007), the
activity of 2TU on the growth of MNV-1 has not been documented.
Within the non-cytotoxic range of concentrations (0–100 μM), both
2TU and ribavirin were found to exhibit an inhibitory effect on the
replication of MNV-1 in RAW 264.7 cells (Fig. 1A). A concentration
of ~25 μM of 2TU was sufﬁcient to reach 50% of inhibition of MNV-1
induced cell death. Notably, the inhibitory effect of 2TU was signiﬁ-
cantly higher (up to 5-fold) than that of ribavirin. This observation
was in accordance with the previously published report for the
inhibition of FCV replication in CRFK cells (Belliot et al., 2005),
where 2TU was found to be more potent than ribavirin. Both plaque
reduction and RT-PCR analysis further proved the potency of 2TU
where 10 μM of 2TU was sufﬁcient to signiﬁcantly reduce the level
of viral plaque formation and RdRp gene expression, respectively
(Figs. 1B and C). Simultaneous and post-treatment of 2TU or ribavirin
produced higher inhibitory effect on cell death than pre-treatment.
To study the possible interactions between MNV-1 RdRp and li-
gands, the effects of temperature on protein stability were
monitored by differential scanning ﬂuorimetry (DSF), in which the ex-
tent of the temperature shift in denaturation proﬁles is proportional
to the afﬁnity of the ligand for a given protein (Vedadi et al., 2006). A
ligand concentration of 10–20 mM was necessary to shift the Tm by 2–
3 °C. The transition temperature (Tm) of RdRp native was 36.5 °C,
whereas it was 38.5 °C and 39.5 °C for the ribavirin and 2TU complexes,
respectively (Fig. 1D). This result complemented the viral inhibition
studies described above, suggesting the binding of 2TU or ribavirinD
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Fig. 1. Viral inhibition and DSF analysis. (A) Effects of 2TU (black) or ribavirin (light
gray) on MNV-1 infection in RAW 264.7 cells. Pre-treatment of RAW 264.7 cells with
2TU or ribavirin in various concentrations for 1 hr followed by infection with MNV-1
at MOI of 0.01 using 96-well plates (upper panel), Simultaneous-treatment with
MNV-1 in the presence of 2TU or ribavirin (middle panel), and post-treatment with
MNV-1 for 1 hr followed by the addition of 2TU or ribavirin in various concentrations
(lower panel). The virus infected cells were incubated for an additional 3 days and
MNV-1 induced cytopathic effect (CPE) was determined by MTT cell viability reduction
assay. Error bars represent standard deviations from at least three replicates. Values
obtained from non-infected and infected cells by MNV-1 only in the absence of ribavi-
rin or 2TU were 2.169±0.09 and 0.266±0.05, respectively, showing MNV-1 induced
CPE. Signiﬁcant increase in cell viability was indicated by asterisks (Pb0.05) and
mean±standard deviations were shown from at least three replicates. (B) Plaque re-
duction assay. MNV plaques were compared at different MOI at simultaneously treated
in MNV innoculum (left panel) or treated post-infection on the cells (right panel).
(C) Effects of 2TU or ribavirin on MNV infection to the cells analyzed by RT-PCR. Simul-
taneous treatment during MNV inoculation (left panel) and post-treatment (right
panel) at concentrations of 10–100 μM. Cells were harvested and viral RNA RdRp
gene was analyzed by RT-PCR with GAPDH as endogenous control gene. (D) Differen-
tial scanning Fluorimetry (DSF) transition curves of MNV-1 RdRp in the presence of
2TU or ribavirin.
145I. Alam et al. / Virology 426 (2012) 143–151with MNV-1 RdRp. Within the same concentration range of ligands, Tm
value shift was higher for 2TU (~3 °C) in comparison to ribavirin
(~2 °C), suggesting the higher afﬁnity of 2TU than ribavirin. Similar
studies have been performed in poliovirus polymerase where addition
of NTP increases the Tm value by 5–6 °C (Thompson et al., 2007). To de-
termine the strength of binding for these ligands (2TU and ribavirin)
isothermal titration calorimetry experiments were carried out to deter-
mine the afﬁnity (Kd) of ligands with the protein. MNV-1 RdRp binds to
2TU with a Kd=0.865±0.4 μM, although we failed to get a Kd for riba-
virin despite trying various concentrations of ligand and protein. Based
on the results of cytopathic effect, plaque reduction assay, RT-PCR, and
DSF, ribavirin is likely to have much lower value of Kd to MNV-1 RdRp,
in comparison to 2TU. In fact, there are no reports available for the Kd
of viral RdRp with ribavirin.
Overall structures
The overall structures of MNV-1 RdRp in complex with the ligand
(2TU or ribavirin) revealed a right hand fold with palm, ﬁngers,
thumb, and N-terminal domains (Supplementary Fig. S1), which
was essentially identical to those reported previously (Ferrer-Orta
et al., 2007; Hogbom et al., 2009; Lee et al., 2011; Ng et al., 2004;
Zamyatkin et al., 2008; Zamyatkin et al., 2009). It adopts an enclosed
conformation where the extended N-terminal domain bridges across
the ﬁngers and thumb domains. Structural superposition using
secondary structure matching (SSM) (Krissinel and Henrick, 2004)
between the native (PDB ID: 3QID) and 2TU or ribavirin-complexed
structures of MNV-1 RdRp gave an r.m.s.d of 0.46 Å or 0.64 Å, respec-
tively. The ligand complexed structures (2TU and ribavirin) showed a
few variations from that of native in the loop regions comprising of
residues 374–381, 434–440 and 466–478 (data not shown). The loop
region comprising of these residues are not superposed well with that
of native structure. These structural differences are attributed to the
intrinsic ﬂexibility of the loops which were also reported in other viral
polymerase structures (Hogbom et al., 2009; Ng et al., 2004). In the
2TU-complex structure, residues 468–475 in chain A and residues
437–440 and 467–474 in chain Bweremissing due to lack of convincing
electron density, and residues 467–474 in chains A and C were not
modeled in the ribavirin complex. In contrast, the same loops were
well resolved in all the three chains of the native and 5-ﬂuorouracil
(5FU)-complex structures of MNV-1 RdRp (Lee et al., 2011). The
amino acid residues in these loops of the 2TU or ribavirin complex
structure showed the highest B factors, indicating increased ﬂexibility
in the crystal. The complex structures suggest that the presence of li-
gand might have disrupted local crystal packing, possibly resulting in
the perturbation of loops of the monomers in the asymmetric unit.
The loop regions were also reported to be perturbed in HuNoV RdRp
in complex with CTP and NCT (Zamyatkin et al., 2008).
Interestingly, disulﬁde bond formation was observed between
Cys206 and Cys307 in the 2TU or ribavirin complex structure of
MNV-1 RdRp, which was not observed in the native as well as the
5FU-complex of MNV-1 RdRp (Supplementary Fig. S2). It was also
observed in an archaeal RNA polymerase but its biological
signiﬁcance has not been described (Hirata et al., 2008). The amino
acid residue Cys307 which is close to the active site was found to
move toward Cys206 forming a disulﬁde bond. Given that the crystal-
lization conditions for both the ligand complexes as well as the native
enzyme were almost identical, it is highly likely that the ligand bind-
ing induces a conformational change which is stabilized by disulﬁde
bond formation between Cys206 and Cys307.
The MNV-1 RdRp–ligand complexes
Initial attempt to get the crystal structure of the MNV-1 RdRp–
ligand complex by soaking the enzyme crystals with ligands indifferent soaking time and concentrations was not successful and
soaking with 2TU seriously cracked the crystals. The ligands were dis-
solved in DMSOwhich seems to have a damaging effect on RdRp crys-
tal packing. As soaking with ligands was not successful, we switched
over to co-crystallization of the complex. The crystal structure of
FMDV RdRp in complex with ribavirin triphosphate (RTP) was
obtained by soaking RdRp with RTP for 6 hrs (Ferrer-Orta et al.,
2007). Initial analysis of the difference electron density maps be-
tween the complex and the native showed the presence of extra den-
sity that would correspond to the ligand occupying a position at the
active site of MNV-1 RdRp (Supplementary Fig. S3). The resulting
2Fo–Fc and Fo–Fc electron density and composite omit maps
substantiated the location and orientation of 2TU or ribavirin and
careful manual rebuilding with further reﬁnement allowed conﬁdent
assignment of surrounding amino acid residues that were omitted
from the initial model to eliminate model bias (Figs. 2A and B).
There are three molecules in the asymmetric unit and the map feature
was found to be better in chains A and C of the 2TU complex as com-
pared to chains A and B of the ribavirin complex. Modeling was done
in all the three chains of 2TU or ribavirin with different occupancies:
2TU with occupancy of 0.69 in chain A and 0.57 in chains B and C, and
ribavirin with occupancy of 0.78 in A and B and 0.80 in chain C. The
average B factors for 2TU were 38.3 Å2, 42.5 Å2 and 35.4 Å2 and
those for ribavirin were 38.5 Å2, 55 Å2 and 70.8 Å2 for chains A, B
and C, respectively. The presence of signiﬁcant electron density
together with relatively high occupancy of the ligands indicates rela-
tively tight binding for 2TU in comparison to ribavirin as evident from
the dissociation constant (Kd=0.865±0.4 μM), DSF and RT-PCR
studies carried out in the presence of the ligand.
The structural superposition of three individual RdRp monomers
in the 2TU and ribavirin complexes showed r.m.s.d values of
0.6–0.8 Å and 0.4–0.6 Å, respectively. The binding orientation of 2TU
in monomer A was slightly different from that in monomer B
(Supplementary Fig. S4). The ambiguity in chain B could be attributed
to the weak electron density map as well as the resolution limits of
the dataset, at which it was difﬁcult to ascertain the correct orienta-
tion of the molecule. Similarly in the ribavirin complex structure,
the ligand molecule showed slightly different orientation in different
chains (Supplementary Fig. S4), but the binding mode was similar.
This difference can be attributed to the local conformational changes
in the side chains of amino acids at the active site.
Superimposing the structures of the 2TU and ribavirin complexes
using SSM gave r.m.s.d of 0.5 Å, indicating relatively low variability
in the ligand-bound structures of MNV-1 RdRp. However, a compari-
son of the active site between the native and the complexes revealed
interesting structural features. First, the amino acid residues involved
in the interaction with metal ions and 2TU or ribavirin were well
superimposed except for two arginine residues Arg185 and Arg395
(Fig. 3A). Deviation was signiﬁcantly higher in Arg395 than Arg185.
The B-factors for the side chains in the native structure were in the
range of 40–45 Å2, whereas those in the 2TU complex were 70 Å2
for Arg395 and 45 Å2 for Arg185. In the ribavirin complex, the B
factors for Arg185 and Arg395 were 50 and 80 Å2, respectively.
Higher B-factors of the residue in the complex structures suggest
local conformational changes upon ligand binding.
Second, superposition of the RdRp structures in complex with the
ligand (2TU or ribavirin) and 5FU of which the complex structure was
previously reported (Lee et al., 2011) showed an r.m.s.d of 0.7 Å. The
active site is rich in aspartate residues which are highly conserved
and actively involved in RdRp enzyme catalysis. These residues
underwent conformational changes that were different from those
induced by 5FU binding. Residues Asp243 and Asp245 were oriented
differently at the active site of both the 2TU- and ribavirin-bound
complexes in comparison to that found in the 5FU-bound complex
structure (data not shown). It was also noticeable that the side
chain orientation of Arg395 in the 2TU or ribavirin complex structure
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147I. Alam et al. / Virology 426 (2012) 143–151was very different from that of the 5FU, whereas that of Arg185 did
not change signiﬁcantly. In addition, residues including Asp250,
Ser303, Thr308, Thr309, Asn312, Tyr344, and Gly345 were involved
in the interaction with 2TU or ribavirin (see below), while the same
interactions were not found in 5FU binding (Lee et al., 2011). Taken
together, the binding of 2TU or ribavirin to the enzyme appears to
result in more open active site structures, in comparison to that of
native or 5FU complex structure.
Interaction of MNV-1 RdRp active site with 2TU or ribavirin
Binding mode of 2TU or ribavirin in MNV-1 RdRp is quite similar
to that observed in other ligand-bound structures of RdRp. However,
the position of ligands at the active site of the enzymewas found to be
slightly shifted in comparison to the other RdRp structures (Ferrer-
Orta et al., 2007; Zamyatkin et al., 2008, 2009), which may be
attributed to the absence of RNA and triphosphate. The triphosphate
moieties of ligands are known to interact with basic Arg residues in
the active site. They are also known to have a signiﬁcant effect on
the electron density of ligands (Campagnola et al., 2011). In the ab-
sence of triphosphate moiety, the ligands (2TU and ribavirin) can be
differently oriented in the active site of MNV-1 RdRp. A comparative
analysis with the HuNoV structure (3H5Y) shows that the orientation
of ribose ring is quite similar in both the cases (Supplementary Fig.
S5). The ligands in our structures are non-phosphorylated and
revealed different orientation from the already known one. The orien-
tation reported in this manuscript was the best ﬁt after many at-
tempts with different orientations for these non-phosphorylated
ligands. However, we do not rule out the possibility that the presence
of phosphate at the ribose ring may orient the ligands similar to the
already known conformations. In both the 2TU and ribavirin-bound
complex structures, the 2′-hydroxyl group of the ribose ring accepts
a hydrogen bond with the side chain of Asn312 and donates a hydro-
gen bond to Thr309 (Fig. 3B). On the contrary, in HuNoV CTP complex
(PDB ID: 3H5Y), 2′-hydroxyl group accepts a hydrogen bond from
Asn309 and donates a hydrogen bond to Ser300 (Zamyatkin et al.,
2008). The highly conserved Ser303 residue (corresponding to
Ser300 of HuNoV) in MNV-1 RdRp is far from the 2′-hydroxyl group
to accept a hydrogen bond (5–7 Å) and instead makes hydrogen
bonds with two water molecules in both the 2TU and ribavirin struc-
tures (Fig. 3B). Thr309 also forms H-bond with the 3′-hydroxyl group
of ribose ring in the 2TU complex structure. These residues are well
conserved at the active site of viral RdRp proteins. The amino acid res-
idue Asp250 (corresponding to Asp247 of HuNoV) interacts directly
with the 5′-hydroxyl group of 2TU as well as a water molecule.
Asp250, Ser303, Tyr344, Gly345 and Asp347 at the active site form
both polar and hydrophobic interactions with 2TU and a number of
water molecules are found to stabilize the interactions of the ligand
with the active site residues. The uracil ring of 2TU is positioned in a
pocket formed by residues Asp250, Tyr344, Asp346, and Asp347. Nota-
bly, the S atom at the uracil ring is interacting with the carboxyl groups
of Asp250 and the N3 atom interact with Asp346 by forming hydrogen
bonds. In contrast, Asp250 forms a hydrogen bondwith the 4′-hydroxyl
group of ribose ring through a water molecule in the ribavirin-bound
structure (Fig. 3B). The ribose ring of ribavirin induces a slight shift in
the backbone of Ser303 and Thr309 to accommodate the larger size of
ribavirin, while that of 2TU is shifted towards Asp250 by 1.2 Å,
compared with that of ribavirin. The ligand is further stabilized by the
formation of a hydrogen bond between N2 and N3 of ribavirin and the
carboxyl group of Asp346. Besides these, hydrophobic interactions
between the ligand and amino acids Ser303, Thr309 and Gly345 have
been observed in the ribavirin complexed structure. This highlyFig. 2.MNV-1RdRp ligand complex and electron densitymaps. (A) Stereoviews of the 2|Fo|–|Fc| ele
MNV-1 RdRp are shown at 1.0σ and 0.8σ. The composite omit map is colored in grey. (B) Stereovie
for ribavirin in complex with MNV-1 RdRp is shown at 1.0σ and 0.9σ. The composite omit map fconserved pattern of interactions is known to be responsible for distin-
guishing ribonucleotides from 2′-deoxyribonucleotide.
A schematic diagram of the interactions was generated using
LIGPLOT (Fig. 3C) (Wallace et al., 1995). Notably, the two arginine
residues Arg185 and Arg395 are not involved in direct interactions
with 2TU. Only the 4-hydroxyl group of 2TU is forming a weak hydro-
gen bond to a water molecule which in turn interacts with Arg185. In
contrast, the side chain of Arg395 adopts a different rotamer confor-
mation in the ribavirin complex structure. The carboxamide group
of ribavirin is hydrogen bonded to both Arg185 and Arg395 through
a water molecule. Arg185 which is highly conserved is known to
bind to the rNTP α-phosphate group, occupying a similar position in
all available viral RdRp structures including distantly related HIV
reverse transcriptase (Zamyatkin et al., 2008). Arg395 which is highly
ﬂexible together with Arg185 is implicated in coordination with
phosphate groups of bound nucleotides. Our complex structures
thus strongly suggest that Arg185 and Arg395 determine the orienta-
tion of ribavirin and 2TU, giving rise to diverse modes of interaction in
the absence of phosphate and RNA, and the difference in interactions
may be attributed to smaller size of 2TU in comparison to ribavirin.
Ligand-induced conformational changes at the active site
In order to further analyze the structural changes taking place at
the active site in the absence of RNA and phosphate groups, we com-
pared the structures of the MNV-1 RdRp complexes with HuNoV
RdRp in complex with RNA and CTP (PDB IDs: 3BSO and 3H5Y)
(Zamyatkin et al., 2008, 2009). The sequences of MNV-1 and HuNoV
RdRps have a high similarity (59%) and the active site residues inter-
acting with the ligands are identical in the two proteins, except for
Thr309 in MNV-1 RdRp which corresponds to Ser306 in HuNoV
RdRp. The overall r.m.s.d. difference of the superposition was found
to be 1.0 Å. However, the ligands in MNV-1 RdRp complexes show a
slightly different orientation from that of CTP, which is possibly due
to the presence of triphosphate and RNA molecule which can make
Watson and Crick hydrogen bonding with incoming rNTPs or their
analogues. In our complex structures, surprisingly, the absence of
RNA or triphosphate does not seem to affect the ligand binding of
2TU or ribavirin at the active site of MNV-1 RdRp, where the amino
acid residues adopt a different rotamer conformation (Fig. 3B). Both
Arg185 and Arg395 are known to be important for the ligand interac-
tion in the presence of triphosphate group. The phosphate group of
CTP in the HuNoV RdRp complex is oriented closer to (Arg182),
thereby making a direct hydrogen bond (Supplementary Fig. S5). Im-
portantly, the side chain conformation of Arg185 in MNV-1 RdRp is
not affected even in the absence of RNA and phosphate. Arg395 is
closer to the active site in comparison to its HuNoV counterpart
(Arg392) which is too far away (~7 Å) to interact with CTP, but it
adopts different conformations depending on the presence or ab-
sence of ligand, as evident from its high B-factor in the ligand
bound structures. In order to understand further regarding the bind-
ing mode in different RNA polymerases, we compared our MNV-1 li-
gand structures with some poliovirus RdRp (PDB IDs: 2IM0 and 3OL7)
reported earlier (Gong and Peersen, 2010; Thompson et al., 2007).
The active site residues are highly conserved and GDD motifs of
MNV-1 RdRp are well superposed with that of poliovirus RdRp. The
active site residues which are involved in ligand interaction were
well superposed with their corresponding partners in both structures.
The ligand was inversely oriented in MNV-1 RdRp in comparison to
poliovirus ligands. The ribose ring was found to be shifted by a
distance of 3.5–5.0 Å in poliovirus RdRp. The difference in position
as well as orientation can be attributed to triphosphate moiety inctron densitymaps (upper) and composite omitmaps (lower panel) for 2TU in complexwith
ws of the 2|Fo|–|Fc| Fourier electron densitymaps (upper) and composite omitmaps (lower)
or ribavirin is colored in black.
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active site in comparison to the non-phosphorylated ligands.
Metal ion bound in MNV-1 RdRp complexes
In the native MNV-1 RdRp structure, the position of a metal ion
which was conﬁrmed in anomalous difference maps clearly showed
a peak possibly for Mn2+ ion (Lee et al., 2011). Although the enzyme
catalysis of RdRp was suggested to be mediated by two metal ion
mechanism (Steitz, 1998), only one metal ion could be modeled in
the vicinity of the active site. This metal ion was coordinated with
the carboxylate groups of Asp243 and Asp347 and the main chain car-
bonyl atom of Ser392 in ranges from 2.6 to 2.8 Å (Fig. 3B). A water
molecule modeled in close proximity of the metal ion was shown to
interact with Asp243 and Asp347 in the 2TU or ribavirin complexes.
The position of metal ion was found to be similar to that of HuNoV
RdRp (3H5Y), where Asp347 (corresponding to Asp344 in HuNoV-1
RdRp) interacts with the metal ion. Asp346 in MNV-1 RdRp is super-
imposed well with its HuNoV counterpart (Asp343), which is shown
to interact with the water molecule that is modeled instead of a metal
ion in MNV-1 RdRp. Notably, the side chains of both Asp243 and
Asp245 are oriented differently from their HuNoV counterparts
(Asp242 and Asp243, respectively). A total of four metal ions were
found at the active site of the CTP-bound structure of HuNoV RdRp
(Zamyatkin et al., 2009). The absence of the second peak for Mn2+
ions in anomalous difference maps of MNV-1 RdRp might be due to
the fact that this site may not always be occupied by Mn2+ ion, and
instead either Mg2+ or a water molecule that is present at the active
site. Interestingly, a signiﬁcant difference in the position of the metal
ion was observed in the 5FU-bound structure, which led to a different
orientation of the side chains of Asp243 and Asp245 in the 5FU-bound
structure of MNV-1 RdRp (Lee et al., 2011). The corresponding aspar-
tate residues (Asp238 and Asp239) of FMDV RdRp are involved in
metal binding where only one Mn+2 ion was reported at the active
site (Ferrer-Orta et al., 2007). The network of interactions in the
RdRp–ribavirin complex is also similar to that of the complex of
FMDV RdRp with RTP.
Implications of ribavirin or 2TU binding to RdRp
Acute gastroenteritis caused by norovirus is a potential threat to
human health, but effective antivirals or vaccines against this virus
are not yet available. A number of RNA virus mutagens other than ri-
bavirin are known (Holland et al., 1990; Lee et al., 1997), but they are
unacceptable for use in humans at the necessary doses due to high
cellular toxicity (Crotty et al., 2002). Ribavirin has been used as an
antiviral prodrug which is metabolized to active 5′-monophosphate,
diphosphate and triphosphate in vivo (Wu et al., 2003). In this
study, the structures of MNV-1 RdRp-2TU and RdRp–ribavirin com-
plexes conﬁrm the binding of the ligand at the active site of viral poly-
merases, which is complemented by the DSF results.
Our biochemical studies revealed stronger inhibitory effect of 2TU
on the replication of MNV-1 in RAW 264.7 cells, compared to that of
ribavirin. The compound 2TU was also found to have an inhibitory ef-
fect on the viral growth in FCV and was the most effective inhibitor of
viral polymerase activity among 5-iodouridine, pseudouridine, 5-
methyluridine, 6-azauridine, and ribavirin (Belliot et al., 2005). The
high potency of 2TU is now conﬁrmed by our studies on MNV-1 inFig. 3. Active site in MNV-1 RdRp complex structures. (A) Superposition of the active
sites of MNV-1 RdRp complexed with 2TU (yellow) and ribavirin (cyan). (B) Stereo-
view of the 2TU (upper) and ribavirin (lower) at the active site of MNV-1 RdRp. 2TU
and ribavirin are shown in a ball and stick model in magenta and yellow color, respec-
tively. Purple sphere represents the metal ion, while white sphere represents water
molecules. Dotted lines represent the various possible interactions. (C) The mode of in-
teractions are represented by LIGPLOT in one of the chains of 2TU (upper) and ribavirin
(lower) complexes.
Table 1
Data and reﬁnement statistics.
Ribavirin 2TU
Data statistics
Wavelength (Å) 1.000 1.000
No. of reﬂections (unique) 564,425 (78,946) 630,236 (113,874)
Resolution range (Å) 50.0–2.50 (2.59–2.50) 50.0–2.20 (2.28–2.20)
Completeness (%) 100 (100) 99.4 (98.6)
Rmerge (%)* 9.30 (46.1) 11.1 (46.1)
I/sigma 21.41 (4.65) 12.5 (2.33)
Mean redundancy 7.1 5.5
Space group C2 C2
Unit cell parameters a=119.9 a=120.7
b=196.0 b=195.9
c=109.2 c=109.3
α=γ=90°β=114° α=γ=90°β=114°
Reﬁnement statistics
Resolution range (Å) 47.84–2.50 31.62–2.20
No. of reﬂections 78,903 113,865
R/Rfree (%) 18.1/22.8 20.2/25.2
r.m.s Deviation
Bonds (Å) 0.008 0.009
Angles (°) 1.14 1.22
Number of water molecules 483 543
Average B (Å2) 29.51 27.9
Ramachandran statistics
Most favored region (%) 91.4 89.3
Additionally allowed region (%) 7.5 8.4
Outliers (%) 0.5 0.9
*Rmerge=Σ|I−b I> |/Σb I>, where I andb I>are the measured and averaged intensities
of multiple measurements of the same reﬂection, respectively. The summation is over
all the observed reﬂections.
**R=Σ|Fo−Fc|/Σ|Fo| calculated for all observed data. Rfree=Σ|Fo−Fc|/Σ|Fo| calculated
for a speciﬁed number of randomly chosen reﬂections that were excluded from the
reﬁnement.
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the question remains: while the inhibitory effect of 2TU is much
higher than that of ribavirin, their complex structures in this study
did not show signiﬁcant difference between two ligands. The number
of interactions and the amino acid residues of RdRp involved in the
interactions with 2TU are very similar to those with ribavirin if the
ligand size is taken into consideration (Supplementary Table S1). It
is also likely that 2TU may bind to other viral or host factors which
may inﬂuence on viral replication. Nevertheless, low cellular toxicity
and highly antiviral activity of 2TU on MNV-1 makes it an obvious
choice for the search of novel antiviral pharmacophores. Further
studies will be done for the search of novel lead compounds based
on 2TU nucleus which can be effective in norovirus inhibition.
In conclusion, our structures reveal the binding modes of 2TU and
ribavirin in norovirus, which highlights the conserved network of in-
teractions involved in viral enzyme catalysis in the absence of RNA
and phosphate groups in the ligand. As the structure of RdRp has
been found to be conserved across different viruses, the structural
results presented here will encourage the rational design of novel
antiviral based on the 2TU and ribavirin nucleus as well as related
pharmacophores. The absence of RNA and phosphate groups from
our structure further opens up ample scope to use this as the starting
model for designing some non-nucleoside based inhibitors which are
still missing for calicivirus RdRp. Such studies will be helpful in our
understanding of the viral enzyme catalysis and will make us better
prepared against the RNA virus.
Materials and methods
Plasmid preparation and protein puriﬁcation
Subcloning, protein extraction and puriﬁcation of MNV-1 RdRp
used for the structural studies have been done as described previous-
ly (Lee et al., 2011).
Effect of 2TU and ribavirin on MNV-1 infected RAW 264.7 cells
RAW 264.7 cells were grown in Dulbecco's Modiﬁed Eagle's Medi-
um (DMEM) (Invitrogen, Grand Island, NY, USA) supplemented with
10% heat-inactivated fetal bovine serum (Sigma-Aldrich, St. Louis,
MO, USA) and 1% penicillin and streptomycin (Invitrogen, Grand Is-
land, NY, USA). MNV-1 was propagated in RAW 264.7 cells in
DMEM Medium (without supplement) for 3–4 days and the titer
was observed as 4×105 PFU/ml by plaque assay. Ampliﬁed MNV-1
viral stocks were stored at −70 °C.
The inhibitory effect of 2TU (Berry and Associates, USA) or ribavi-
rin (Sigma-Aldrich, St. Louis, MO, USA) on MNV-1 was analyzed by
cytopathic effects (CPE) inhibition assay, plaque reduction assay and
RT-PCR. RAW 264.7 cells were seeded in 96-wells at a density of
1–2×105 cells/well 12–24 hrs prior to the experiments. When the
conﬂuence of RAW 264.7 cells reached 70–80% they were infected
with MNV-1 (MOI 0.01). MNV-1 and an inhibitor were added into
these cells in three different ways. First, MNV-1 was infected into
conﬂuent RAW 264.7 cells in the absence or presence of 2TU or riba-
virin. Second, MNV-1 was pre-infected into conﬂuent RAW 264.7 cells
for 1 hr and 2TU or ribavirin was added in various concentrations
(0–100 μM). Third, conﬂuent RAW 264.7 cells were pre-treated with
2TU or ribavirin for 1 hr in different concentrations (0–100 μM),
which was then infected with MNV-1 (MOI 0.01). The virus infected
cells were incubated for 3 additional days at 37 °C under 5% CO2 at-
mosphere and MNV-1 induced CPEwas determined byMTT cell viabil-
ity reduction assay. The absorbance was measured at 570 nm using a
multiplate reader (Molecular devices, Spectro Max M2). MNV-1 in-
duced CPE was assessed by monitoring the absorbance of non-
infected cells minus that of virus infected non-treated cells (mock trea-
ted cells). Cell survival in the presence of 2TU or ribavirin wasdetermined by comparing with mock treated cells. Values obtained
from non-infected cells and cell infected by MNV-1 in the absence of
2TU or ribavirin were set to 100% and 0% (y-axis), respectively, and %
of control was calculated as (Ab−Absmnv-1)/(Absnoninfected cell
−Abs)×100. All the experiments were replicated three times to mini-
mize the error. Ribavirin and 2TU were used in non-cytotoxic range (0
to 100 μM). The antiviral activity was expressed as mean±SD for
three independent experiments. Means were evaluated by one-way
ANOVA and used to compare the difference between the each group
using Post-Hoc test byDucan'smethod. P value of b0.05was considered
statistically signiﬁcant.
Plaque reduction assay
Plaque reduction assay was carried out to compare the effect of li-
gands on the replication of MNV-1. RAW 264.7 cells were seeded into
24-well plates with DMEM, 5% FBS and 1% penicillin-streptomycin at
a density of 1.5×106/well. After 12–16 hrs RAW 264.7 cells with MOI
0.1–0.001 were infected with MNV-1. A ligand (2TU or ribavirin) at a
concentration range of 10–100 μM was added simultaneously or post
virus infection. Cells were grown for 42 hrs at 37 °C under 5% CO2, and
were ﬁxed and stained with 4% formaldehyde 0.5% crystal violet.
RT-PCR analysis
RAW 264.7 cells were seeded into 6-well plates with DMEM, 5%
FBS and 1% penicillin–streptomycin at a density of 4–5×106/well.
After 12–16 hrs, 10 μM 2TU or 100 μM ribavirin was simultaneously
treated during MNV-1 inoculation (MOI 0.01) onto RAW 264.7 cells
for 1 hr and ligands were removed from cells. Cells were incubated
with fresh complete media for 1 or 2 days. In case of post-
treatment, 10–100 μM 2TU or 100 μM ribavirin was treated into com-
plete media after MNV-1 infection onto RAW 264.7 cells for 1 hr. At
150 I. Alam et al. / Virology 426 (2012) 143–151the post-infection for 24–48 hrs, cells were harvested and viral RNA
was extracted by RNeasy kit (QIAGEN, Valencia, CA, USA), according
to the manufacturer's instructions. OligodT, random hexamer and
RdRp primers (Bioneer, Daejon, Korea) were used to synthesize
cDNA by MMLV reverse transcriptase (RT-&GO™ Master Mix kit,
MP, USA) and were analyzed by RT-PCR. GAPDH (GAPDH-F, AAC-
GACCCCTTCATTGAC and GAPDH-R, TCCACGACATACTCAGCAC) was
used as endogenous control gene. PCR was performed using the
RdRp and GAPDH primers with an initial denaturing at 94 °C for
5 min, followed by 35 cycles of denaturing at 94 °C for 1 min, anneal-
ing at 60 °C for 1 min, and extension at 72 °C for 1 min and then a
ﬁnal extension at 72 °C for 5 min. PCR products were subjected to
1.5% agarose gel electrophoresis.
Isothermal titration calorimetry (ITC)
ITC experiments were performed using VP-ITC calorimeter from
Microcal (Northampton, MA, USA). Experiments were carried out by
titrating MNV-1 RdRp (50 μM) with 2TU (1.5 mM) at 15 °C. A total
of 30 injections were performed at a spacing of 300 s and a reference
power of 10 μcal/sec. Control experiments to determine the heat of
dilution for each injection were performed by injecting the same vol-
ume of 2TU into sample cell containing only buffer. The heat of dilu-
tion generated by the compounds was subtracted and the binding
isotherms were plotted and ﬁt to a single site binding model using or-
igin ITC software.
Differential scanning ﬂuorimetry (DSF)
In order to conﬁrm the binding of 2TU or ribavirin to MNV-1 RdRp
we used the DSF method which measures the shift in Tm upon ligand
binding. MNV-1 RdRp at a concentration of 1 mg/ml (16.5 μM) was
incubated with a ligand (2TU or ribavirin) in concentrations ranging
from 1 to 20 mM overnight. Samples were prepared by mixing
0.5 μl (500-fold) SYPRO Orange in the protein mixture and incubated
at 25 °C for 30 s. It was then followed by temperature increment at
the rate of 0.5 °C every 30 s for 50 min and relative ﬂuorescence
units were recorded using Mx3005P differential scanning ﬂuorimetry
(Stratagene, CA, USA). The excitation wavelength was 492 nm and
the emission wavelength was 610 nm. Tm was calculated from the
maxima of the ﬁrst derivative of relative ﬂuorescence units/tempera-
ture using MxPro QPCR Software.
Crystallization and data collection
The homogenous fractions of the puriﬁed RdRp were pooled and
concentrated up to ~3 mg/ml using a 10 kDa cut-off membrane ﬁlter.
The concentrated RdRp was incubated separately with 20 mM 2TU or
ribavirin at 4 °C overnight and crystals were screened by sitting drop
method using commercial kits (Emerald Biosystems, Bainbridge Is-
land, USA). Good quality crystals for ribavirin were observed in
2–3 days after incubation at room temperature in 1.26 M ammonium
sulphate, CHES (pH 9.5) and 0.2 M NaCl, which was further reﬁned by
hanging dropmethod with varying pH range (9.0–10.0) and ammoni-
um sulphate concentration (0.8-1.4 M). For 2TU diffraction quality
crystals were found in 2.0 M ammonium sulphate, cacodylate pH
6.5 and 0.2 M sodium chloride.
Diffraction quality crystals were transferred to the mother liquor
(approximately 30% higher concentrations than the reservoir solu-
tion) containing 22% glycerol as cryoprotectant prior to mounting
for data collection. Crystals diffracted at a resolution of 2.5 Å for riba-
virin while the resolution for 2TU was 2.2 Å. In order to identify the
position of a metal ion, a crystal was soaked in 10 mM MnCl2 for 30
minutes and anomalous data were collected at the wavelength of
1.89 Å. Diffraction data were collected with crystals ﬂash-cooled at
100 K in a stream of liquid N2 using a synchrotron radiation source,Beamline 4A at Pohang Light Source (Quantum CCD detector, ADSC,
USA). The data were processed using HKL 2000 (Otwinowski and
Minor, 1997). The crystals were of space group C2 with unit cell di-
mensions a=120, b=196, c=109, α=γ=90, β=114 with three
monomers in the asymmetric unit.
Structure solution and reﬁnement
The ligand complex structure was solved using CCP4 for molecular
replacement (Vagin and Teplyakov, 1997), employing a previously
solved structure of the same protein complexed with 5-ﬂuorouracil
(5FU) (PDB ID: 3NAI) as a search model. Molecular replacement
gave a single prominent solution after rotation and translation func-
tion. The initial solution was optimized by rigid body reﬁnement,
which produced a clearly interpretable electron density for the over-
all structure. Density for 2TU or ribavirin was clearly observed at the
active site of MNV-1 RdRp. Manual adjustment of the backbone and
side chain was done in Coot (Emsley and Cowtan, 2004). The side
chains were assigned easily to the model using the electron density
map which was helpful in avoiding any model bias during molecular
replacement. Crystallographic reﬁnement was carried out using the
programs PHENIX and Refmac5 (Adams et al., 2010; Murshudov et
al., 1997). Difference Fourier maps with coefﬁcients 2|Fo|–|Fc| and |
Fo|–|Fc| were used to model 2TU and ribavirin interacting with
amino acid residues at the active site. After a few rounds of model
building water molecules were then added using the Fo–Fc map
peaks above 3.0σ, if the B factors were below 60 Å2 after reﬁnement.
The value of Rfree has been used as an indicator to validate the water
picking and reﬁnement procedure and to avoid any possible over ﬁt-
ting of the data. At the end of reﬁnement residues 1–4 and 493–509
could not be modeled in both ribavirin and 2TU complexed data
due to poor electron density in these regions. The C-terminal His tag
was also missing in all the three chains. The R/Rfree values were
18.1/22.8%, and 20.2/25.2% for ribavirin and 2TU complex data re-
spectively. Data quality and reﬁnement statistics are presented in
Table 1.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.virol.2012.01.016.
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